Top Life Sciences Startups in 2026

H1 was built by scientists for scientists. We empower stakeholders at healthcare and life science companies to make smarter scientific decisions by providing access to critical data through an intuitive interface. Working with some of the largest and most influential global life science organizations, H1 provides insight into thought leaders, scholarly content, academics, and healthcare professionals with much more on the way.

TrialSpark is transforming the way new medical treatments are brought to market. We’re a technology company that runs end-to-end clinical trials through a network of our own TrialSpark-operated trial sites, making the entire lifecycle of clinical trials more efficient, accessible, and patient-centric. We're growing quickly and would love to have you join us!

Candid is redefining oral health by using modern technology to help deliver human-focused care. With a commitment to creating the best outcomes, Candid inspires confidence and promotes wellbeing. We believe that high-quality orthodontics should be affordable and accessible, and we’re pioneering an innovative approach to diagnosing, treating, and monitoring cases remotely. Our team is a group of startup veterans with experience across healthcare, hospitality, tech, and finance at companies such as Lyft, BCG, Airbnb, Blackstone, and Clover Health.

Omada Health is a virtual-first, integrated care provider. We combine the latest clinical protocols with breakthrough behavior science to make it possible for people with chronic conditions to achieve long-term improvements in their health. Working with over 1,600 enterprise customers – including Fortune 500 and small- and medium-sized employers, health plans, and health systems – Omada delivers personalized interventions for diabetes prevention and weight management, diabetes, hypertension, musculoskeletal issues and behavioral health. Our virtual care programs are clinically supported and evidence-based, and the results have been published in multiple peer-reviewed journals. We build programs that employees don’t just try, but stick with – resulting in reduced healthcare costs that deliver long term changes in health behavior and increased ROI. We're especially proud of the clinical results we deliver and the way we leverage technology to amplify and extend the influence of our real human care teams - from health coaches to clinical specialists. Omada has enrolled more than half a million members across all 50 states. Our partners include major employers across the country, including Costco and Iron Mountain, as well as leading health plans, such as Cigna and Kaiser.

Doximity was founded in 2011 by the pioneers of mobile health apps to connect healthcare professionals and make them more productive. Joining Doximity means being part of an incredibly talented and humble team. We work on amazing products that over one million medical professionals, including over 70% of all U.S. doctors and 45% of all NPs and physician assistants, use to make their busy lives a little easier. Here at Doximity we absolutely love creating technology that has a real, meaningful impact on people’s lives.

Relay Therapeutics is building the world’s first dedicated drug discovery platform centered on protein motion to discover and develop new medicines that will make a transformative difference for patients. By placing protein motion at the heart of drug discovery, Relay is pursuing what it believes will be a fundamental paradigm shift within the pharmaceutical industry, ushering in a new generation of drugs with the potential to improve and extend the lives of millions of patients. Headquartered in Cambridge, Mass., Relay Therapeutics is a private company launched in 2016. To date, Relay Therapeutics has raised $120M in financing from Third Rock Ventures, BVF Partners, GV (formerly Google Ventures), an affiliate of D.E. Shaw Research, Casdin Capital, EcoR1 Capital, Section 32 and Alexandria Venture Investments.

As population continues to age, there is a growing demand for motor rehabilitation services. The problem is that the way we address this growth or rehabilitation services (physical therapy) has not changed in thirty years because we are still heavily reliant on a one-to-one patient therapist interaction which is costly, non scalable, and difficult to ensure consistent quality. At SWORD Health, we saw the opportunity to take a truly disruptive and transformative approach to this problem by creating the first digital therapy solution that addresses the growing demand for therapy while reducing costs, empowering patients with their recovery to ultimately recover faster, and providing a rich source of data for clinical teams and decision makers. Video: vimeo.com/118489111

Q Bio is revolutionizing primary care with the first clinical digital twin platform, powered by breakthrough whole-body scanning technology, that highlights the most important changes in a person’s physiology for sharing with physicians and specialists anywhere in the world. The company was founded in 2015 and is headquartered in San Carlos, California. Q Bio was founded by Jeffrey Kaditz, serial entrepreneur and Founder of Affirm, Dr Michael Snyder, Chair of Genetics and Director of Personalized Medicine and Stanford University, and Dr Garry Choy, physician, radiologist, and former Chief Medical Information Officer at Mass General Hospital. We are fortunate to be backed by some of the best venture groups in the world including: A16Z, Khosla Ventures, Founders Fund, SciFi VC, and Kevin Durant.

Gabb Global's advantage is the extensive application of neuroscience perspective and methods that produce the most comfortable environment for someone learning a new language. Our neuroscience research demonstrates our reliability and validity. Our professional linguists and learning experience designers coming together help to create and unforgettable learning experience. Together, we create a flexible and efficient style of immersive learning.

We push the boundaries of molecular diagnostics through quantitative technologies. BillionToOne is a precision diagnostics company with the mission to make molecular diagnostics more accurate, efficient, and accessible for all. Our patent-pending QCT molecular counter platform is the only technology platform that can accurately count the DNA molecules to the single-count level.